NCT05343468

Brief Summary

Enhancing independence and quality of life are key modifiable outcomes that are short- and long-term goals for children with Down syndrome (DS) and for their parents. The study investigated the efficacy of assistive technology in improving children with Down Syndrome's independence and quality of life. Using a commercially available assistive technology, the MapHabit system, the investigators implemented the software with participants' families for 4 weeks. The investigators hypothesized that the assistive technology will improve adaptive behavioral skills and overall quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

9 months

First QC Date

April 5, 2022

Last Update Submit

February 22, 2023

Conditions

Keywords

Down syndromeAssistive technologyAdaptive behavioral skills

Outcome Measures

Primary Outcomes (2)

  • Change in Adaptive Behavior Assessment System Third Edition (ABAS-3) from Baseline at 4 Weeks

    Assessment is used commonly for children with Down syndrome that evaluates conceptual, social, and practical behavioral skills that are significant for day-to-day functioning. The assessment is scored with the General Adaptive Composite (GAC), which summarizes performance across all adaptive skill areas. GAC score ranges from 0-130, with a higher score indicating better outcome.

    Pre-Post: The assessment was administered at the beginning and end of the study's duration (4-week study).

  • Quality of Life - 18 (QoL-18)

    18-item quality-of-life questionnaire (QoL-18) evaluated a range of participants' behaviors, including mood, engagement, and memory at the end of the study compared to before the use of the MHS. The instrument is scored on a Likert Scale, ranging from 1-5. A higher number indicates better outcome.

    The instrument was administered to the participants after the completion of the study duration (4-week study).

Study Arms (1)

Experimental

EXPERIMENTAL

Singe-arm: the assistive digital software was implemented as an intervention to all participants.

Device: The MapHabit System

Interventions

The MapHabit System (MHS) is a commercially available visual mapping software application that utilize visual, audio, and text media to create step-by-step visual guides to assist individuals and their caregivers in structuring and accomplishing activities of daily living (ADLs). The goal of the application is to develop and facilitate habits and routines using structured visual and auditory stimuli that can be customized by the user and can include educational and lesson-based material in addition to ADLs. The application was made available to families through compatible smartphones and tablets. The MHS is a general wellness product and there is no regulatory oversight of the MapHabit System mapping functionality. This functionality is not a regulated medical device.

Experimental

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Down syndrome diagnosis
  • Age between 7-17
  • Internet access
  • Proficiency in English

You may not qualify if:

  • Ages outside of 7-17
  • Located outside of the United States of America
  • No internet access
  • No proficiency in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MapHabit, Inc.

Atlanta, Georgia, 30308, United States

Location

Related Publications (4)

  • Boatman F, Golden M, Jin J, Kim Y, Law S, Lu A, Merriam N, Zola S. Assistive technology: Visual mapping combined with mobile software can enhance quality of life and ability to carry out activities of daily living in individuals with impaired memory. Technol Health Care. 2020;28(2):121-128. doi: 10.3233/THC-191980.

    PMID: 31796718BACKGROUND
  • Kelleher J, Zola S, Cui X, Chen S, Gerber C, Parker MW, Davis C, Law S, Golden M, Vaughan CP. Personalized Visual Mapping Assistive Technology to Improve Functional Ability in Persons With Dementia: Feasibility Cohort Study. JMIR Aging. 2021 Oct 19;4(4):e28165. doi: 10.2196/28165.

    PMID: 34269690BACKGROUND
  • Parker MW, Davis C, White K, Johnson D, Golden M, Zola S. Reduced care burden and improved quality of life in African American family caregivers: Positive impact of personalized assistive technology. Technol Health Care. 2022;30(2):379-387. doi: 10.3233/THC-213049.

    PMID: 34334439BACKGROUND
  • White K, Han SS, Britton A, Hendrix J. A feasibility study demonstrating that independence, quality of life, and adaptive behavioral skills can improve in children with Down syndrome after using assistive technology. PLoS One. 2023 May 24;18(5):e0284738. doi: 10.1371/journal.pone.0284738. eCollection 2023.

MeSH Terms

Conditions

Down Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Officials

  • Stuart Zola, PhD

    MapHabit, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: This single-arm repeated measures design examined the effects of a software device as an intervention, permitting the participants to serve as their own controls.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Scientific Officer

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 25, 2022

Study Start

September 20, 2020

Primary Completion

June 18, 2021

Study Completion

August 5, 2021

Last Updated

February 24, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Immediately following publication. No end date.
Access Criteria
Researchers who provide a methodologically sound proposal. Proposals should be directed to szola@maphabit.com. To gain access, data requestors will need to sign a data access agreement.

Locations